Home > News & Media > News
Communication starts here.
2013.06
TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201
2013.05
TWi Pharmaceuticals Announces Tentative ANDA Approval for Guanfacine Hydrochloride Extended-Release Tablets

 

Pages:1 - 2 - 3 - 4 - 5 - 6 - 7« Pre · Next »